Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing
A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.
Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61